课题基金 / 基金详情

General Clinical Research Center

General Clinical Research Center
全科临床研究中心
批准号:
7784531
负责人:
WILLIAM B APPLEGATE
金额:
$364.51万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-02-14 至 2011-08-28

项目摘要

项目成果

WILLIAM B APPLEGATE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Hyperglycemia is frequently encountered when sick newborn infants receive TPN providing glucose exceeding the infant normal glucose turnover rate. Recent studies in critically ill children and adults have demonstrated that hyperglycemia was associated with increased mortality. Since sick newborns,particularly those with very low birth weight also constitute a high-risk population, preventing hyperglycemia without compromising their energy intake, may reduce their risk of an adverse outcome. To accomplish this goal requires detailed knowledge about potential factors involved in the development of hyperglycemia(regulation of glucose production, gluconeogenesis, glycogenolysis, glucose utilization; and insulin secretion and insulin resistance), and the mechanisms by which e.g. insulin infusion and reduced glucose infusion rates affect glucose metabolism to reduce blood glucose. These issues will be addressed by the protocols described in this revised competing renewal grant proposal. The following hypotheses will be tested in 75 ELBW (Extremely Low Birth Weight) infants during a 5 y period: 1. Rates of gluconeogenesis do not change in response to a decrease in concentrations of glucose and insulin resulting from a reduction of the rate of glucose infusion to 3 mg/kg min; 2. Infusion of insulin will a) not acutely suppress rates of gluconeogenesis; b)increase glucose utilization in proportion to body weight; c) increase protein synthesis; 3. In infants receiving standard TPN, hyperglycemia is primarily a result of insufficient insulin secretion. These studies will improve our insight into the regulation of glucose production, gluconeogenesis and glycogenolysis; the pathophysiology of hyperglycemia and the mechanisms by which insulin infusion affects glucose and protein metabolism. A clear understanding of the mechanisms that control glucose homeostasis in the extremely low birth weight infant will permit us to develop evidence besed strategies to maintain euglycemia while providingappropriate energy intake.
期刊论文(484)
专著(0)
科研奖励(0)
会议论文
Cross calibration in longitudinal studies.
纵向研究中的交叉校准。
DOI: 10.1002/sim.1868
发表时间: 2004
期刊: Statistics in medicine.
影响因子: --
作者: [Ambrosius,WalterT, Hui,SiuL]
通讯作者: Hui,SiuL
Can ropivacaine and levobupivacaine be used as test doses during regional anesthesia?
区域麻醉期间可以使用罗哌卡因和左布比卡因作为测试剂量吗?
DOI: 10.1097/00000542-200404000-00023
发表时间: 2004
期刊: Anesthesiology
影响因子: 8.8
作者: [Owen,MedgeD, Gautier,Philippe, Hood,DavidD]
通讯作者: Hood,DavidD
Detecting left ventricular myocardial ischemia during intravenous dobutamine with cardiovascular magnetic resonance imaging (MRI).
使用心血管磁共振成像 (MRI) 检测静脉注射多巴酚丁胺期间左心室心肌缺血。
DOI: 10.1081/jcmr-100000144
发表时间: 2001
期刊: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance
影响因子: --
作者: [Rerkpattanapipat,P, Link,KM, Hamilton,CA, Hundley,WG]
通讯作者: Hundley,WG
Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance.
载脂蛋白 A-IV Q360H 多态性对餐后血浆甘油三酯清除率的影响。
DOI: --
发表时间: 2001
期刊: Journal of lipid research
影响因子: 6.5
作者: [Hockey,KJ, Anderson,RA, Cook,VR, Hantgan,RR, Weinberg,RB]
通讯作者: Weinberg,RB
228
    Human Research Subjects Protections Program Outreach
    Human Rresearch Subjects Protections Program
    ACTIVITY COUNSELING TRIAL
    General Clinical Research Center
    国内基金
    海外基金
    Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data